Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
about
Structure of the extracellular domains of human and Xenopus Fn14: implications in the evolution of TWEAK and Fn14 interactionsPrinciples of antibody-mediated TNF receptor activationFactors regulating immunoglobulin production by normal and disease-associated plasma cellsFusion toxin BLyS-gelonin inhibits growth of malignant human B cell lines in vitro and in vivoSmall Molecule Inhibition of the TNF Family Cytokine CD40 Ligand through a Subunit Fracture MechanismAberrant expression of functional BAFF-system receptors by malignant B-cell precursors impacts leukemia cell survivalBAFF, APRIL, TWEAK, BCMA, TACI and Fn14 proteins are related to human glioma tumor grade: immunohistochemistry and public microarray data meta-analysis.Human BLyS facilitates engraftment of human PBL derived B cells in immunodeficient mice.Characterization of inhibitory anti-insulin-like growth factor receptor antibodies with different epitope specificity and ligand-blocking properties: implications for mechanism of action in vivo.Selective regulation of axonal growth from developing hippocampal neurons by tumor necrosis factor superfamily member APRILThe function of BAFF on T helper cells in autoimmunityAPRIL mediates peritoneal B-1 cell homeostasis.B-lymphocyte homeostasis and BLyS-directed immunotherapy in transplantation.Stable IgG-like bispecific antibodies directed toward the type I insulin-like growth factor receptor demonstrate enhanced ligand blockade and anti-tumor activitySignaling by the tumor necrosis factor receptor superfamily in B-cell biology and diseaseγ-Secretase directly sheds the survival receptor BCMA from plasma cellsRegulatory mechanisms for the production of BAFF and IL-6 are impaired in monocytes of patients of primary Sjögren's syndromeThe design and characterization of receptor-selective APRIL variantsAn APRIL to remember: novel TNF ligands as therapeutic targets.Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials.Understanding cytokine and growth factor receptor activation mechanisms.Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia.Binding efficiency of protein-protein complexes.B-cell survival and development controlled by the coordination of NF-κB family members RelB and cRel.APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa.The BLyS family: toward a molecular understanding of B cell homeostasis.Tonic B cell antigen receptor signals supply an NF-kappaB substrate for prosurvival BLyS signaling.Differential expression of BAFF and its receptors in discoid lupus erythematosus patients.Beyond transitional selection: New roles for BLyS in peripheral toleranceBAFF/BLyS inhibitors: A new prospect for treatment of systemic lupus erythematosus.Breaking the ice in systemic lupus erythematosus: belimumab, a promising new therapy.Aberrant B cell selection and activation in systemic lupus erythematosus.Behçet's syndrome pathophysiology and potential therapeutic targets.Lupus clinical development: will belimumab's approval catalyse a new paradigm for SLE drug development?New roles for the BLyS/BAFF family in antigen-experienced B cell niches.B-cell activating factor in the pathophysiology of multiple myeloma: a target for therapy?B cells biology in systemic lupus erythematosus-from bench to bedside.Lupus nephritis and B-cell targeting therapy.Development of a Novel BAFF Responsive Cell Line Suitable for Detecting Bioactive BAFF and Neutralizing Antibodies against BAFF-Pathway Inhibiting Therapeutics.Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases.
P2860
Q24320262-02FE5B3C-A841-490A-9963-EFA72633920FQ26796270-CD5D67F1-FAC8-4162-BFAC-93E6C250A037Q27021855-FD2016AE-C0A0-49FE-809B-9E0863F0E8AFQ27314650-5C116A0F-A78A-4F87-B8CF-B5C4D118174BQ27667288-F50F076A-E393-426D-A976-7F9C3E71F824Q28743862-7E5E5DBA-AFEE-49B2-BA95-3BD2132D1FC1Q30724766-5EAFF3C6-D8E7-4F6C-95C9-B2C2B4D5AD3CQ33368623-BDF78D2D-2D40-4961-8DC2-7A6494472806Q33408460-A8478C4B-B321-45C0-8809-CC25BB9E59E1Q33559757-6D3662F3-1BF1-4194-99A2-6CC3683F9AC7Q33748041-376BDAE6-5B8A-4E53-86EF-6018B5753720Q33758475-6261E32B-AEC7-496C-8B7A-686F7E8E1BFFQ34159016-9642A62C-E83F-4211-987F-3E9B7E00ED58Q34575855-D978BEDC-2C63-4207-9A7F-5F09C75591E2Q35452032-1EA3304D-441D-47E6-9721-361FAFEA1BC3Q35814239-E52C40DC-8104-4C36-B138-5CB67226AEBEQ35840812-7FFEC696-E628-4ACA-B3E2-7A8921EA0DD3Q36347872-96647BAD-DB32-46C4-AFF5-32B980901D17Q36394955-A2C39990-7FC5-4728-95E0-F247DB98CB92Q36484465-76BD279B-CCEA-475A-8546-871844983BAEQ36509470-2A12C0C8-3188-4636-873E-AE9C1C70D53EQ36530420-EC1F12EB-1586-488D-99F6-27D7F2285448Q36595042-01CE4FA8-669F-49BB-9AF6-AB47A73D56E0Q36675058-8021B6AF-EEE9-4EA0-9D7E-3926AD5BE307Q36749700-BE53FFAC-573F-4119-B962-00E0EFE40C88Q37335169-A7DE7AE7-7E6C-4FFA-A6D6-8B1EB301295EQ37347235-CCCA9070-A18C-46B2-973E-EF0FC7F288ACQ37624045-DB494729-FDD1-4033-8273-CF256176EEA4Q37983058-B004DDC5-E53F-4994-9D64-BCCDE10C0420Q38013996-875DD2E9-17DC-4C65-ADC9-6FED0AC88D87Q38095862-882430E4-6836-458C-80FE-54B72B0B5C0AQ38114501-F2C94620-CD67-4076-BF47-8D2DC1DAD8F3Q38177749-B00EF3E2-134E-4F90-8432-F70640D33CA2Q38184585-B7BA4E60-3925-48A8-B6CA-BBCC6ED58541Q38186321-50C3110E-4394-4014-8DBE-4C8EE8CA4470Q38365867-F56D40CF-21A6-4F7A-A486-4DB7D3F8C772Q38631964-27F2CC07-666F-4BF1-9C97-4150E550A677Q38643755-F45C588E-305D-42C5-BCDB-72A7FCF54161Q38673541-FEFE668A-39C6-4203-9374-D0490E34C4C5Q38755707-88802347-1795-4D43-A249-26625A9D64A9
P2860
Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Selectivity of BAFF/BLyS and A ...... receptors BAFFR/BR3 and BCMA.
@en
type
label
Selectivity of BAFF/BLyS and A ...... receptors BAFFR/BR3 and BCMA.
@en
prefLabel
Selectivity of BAFF/BLyS and A ...... receptors BAFFR/BR3 and BCMA.
@en
P2093
P356
P1433
P1476
Selectivity of BAFF/BLyS and A ...... receptors BAFFR/BR3 and BCMA.
@en
P2093
Adrian Whitty
Dingyi Wen
Eric S Day
Marc Pelletier
Teresa G Cachero
Yaping Sun
Yen-Ming Hsu
P304
P356
10.1021/BI048227K
P407
P577
2005-02-01T00:00:00Z